Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors
Clinical trial NCT03015324 · COMPLETED
Trial details
- NCT number
- NCT03015324
- Sponsor
- Peng Wang, MD PhD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-08
- Primary completion
- 2020-02-03
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.